133 related articles for article (PubMed ID: 9414118)
1. Proteolytic processing of presenilin-1 (PS-1) is not associated with Alzheimer's disease with or without PS-1 mutations.
Okochi M; Ishii K; Usami M; Sahara N; Kametani F; Tanaka K; Fraser PE; Ikeda M; Saunders AM; Hendriks L; Shoji SI; Nee LE; Martin JJ; Van Broeckhoven C; St George-Hyslop PH; Roses AD; Mori H
FEBS Lett; 1997 Nov; 418(1-2):162-6. PubMed ID: 9414118
[TBL] [Abstract][Full Text] [Related]
2. The proteolytic fragments of the Alzheimer's disease-associated presenilin-1 form heterodimers and occur as a 100-150-kDa molecular mass complex.
Capell A; Grünberg J; Pesold B; Diehlmann A; Citron M; Nixon R; Beyreuther K; Selkoe DJ; Haass C
J Biol Chem; 1998 Feb; 273(6):3205-11. PubMed ID: 9452432
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease associated presenilin-1 holoprotein and its 18-20 kDa C-terminal fragment are death substrates for proteases of the caspase family.
Grunberg J; Walter J; Loetscher H; Deuschle U; Jacobsen H; Haass C
Biochemistry; 1998 Feb; 37(8):2263-70. PubMed ID: 9485372
[TBL] [Abstract][Full Text] [Related]
4. Different effects of Alzheimer-associated mutations of presenilin 1 on its processing.
Murayama O; Honda T; Mercken M; Murayama M; Yasutake K; Nihonmatsu N; Nakazato Y; Michel G; Song S; Sato K; Takahashi H; Takashima A
Neurosci Lett; 1997 Jun; 229(1):61-4. PubMed ID: 9224802
[TBL] [Abstract][Full Text] [Related]
5. Proteolytic fragments of the Alzheimer's disease associated presenilins-1 and -2 are phosphorylated in vivo by distinct cellular mechanisms.
Walter J; Grünberg J; Schindzielorz A; Haass C
Biochemistry; 1998 Apr; 37(17):5961-7. PubMed ID: 9558331
[TBL] [Abstract][Full Text] [Related]
6. Presenilin proteins undergo heterogeneous endoproteolysis between Thr291 and Ala299 and occur as stable N- and C-terminal fragments in normal and Alzheimer brain tissue.
Podlisny MB; Citron M; Amarante P; Sherrington R; Xia W; Zhang J; Diehl T; Levesque G; Fraser P; Haass C; Koo EH; Seubert P; St George-Hyslop P; Teplow DB; Selkoe DJ
Neurobiol Dis; 1997; 3(4):325-37. PubMed ID: 9173929
[TBL] [Abstract][Full Text] [Related]
7. Proteolytic processing of Alzheimer's disease associated proteins.
Haass C; Grünberg J; Capell A; Wild-Bode C; Leimer U; Walter J; Yamazaki T; Ihara I; Zweckbronner I; Jakubek C; Baumeister R
J Neural Transm Suppl; 1998; 53():159-67. PubMed ID: 9700654
[TBL] [Abstract][Full Text] [Related]
8. Impaired proteolytic processing of presenilin-1 in chromosome 14-linked familial Alzheimer's disease patient lymphocytes.
Takahashi H; Mercken M; Honda T; Saito Y; Murayama M; Song S; Takashima A
Neurosci Lett; 1999 Jan; 260(2):121-4. PubMed ID: 10025714
[TBL] [Abstract][Full Text] [Related]
9. Proteolytic processing of the Alzheimer disease-associated presenilin-1 generates an in vivo substrate for protein kinase C.
Walter J; Grünberg J; Capell A; Pesold B; Schindzielorz A; Citron M; Mendla K; George-Hyslop PS; Multhaup G; Selkoe DJ; Haass C
Proc Natl Acad Sci U S A; 1997 May; 94(10):5349-54. PubMed ID: 9144240
[TBL] [Abstract][Full Text] [Related]
10. Expression of Alzheimer's disease-associated presenilin-1 is controlled by proteolytic degradation and complex formation.
Steiner H; Capell A; Pesold B; Citron M; Kloetzel PM; Selkoe DJ; Romig H; Mendla K; Haass C
J Biol Chem; 1998 Nov; 273(48):32322-31. PubMed ID: 9822712
[TBL] [Abstract][Full Text] [Related]
11. Homodimerization of presenilin N-terminal fragments is affected by mutations linked to Alzheimer's disease.
Cervantes S; Gonzàlez-Duarte R; Marfany G
FEBS Lett; 2001 Sep; 505(1):81-6. PubMed ID: 11557046
[TBL] [Abstract][Full Text] [Related]
12. Analysis of presenilin 1 and presenilin 2 expression and processing by newly developed monoclonal antibodies.
Diehlmann A; Ida N; Weggen S; Grünberg J; Haass C; Masters CL; Bayer TA; Beyreuther K
J Neurosci Res; 1999 May; 56(4):405-19. PubMed ID: 10340748
[TBL] [Abstract][Full Text] [Related]
13. Zebrafish (Danio rerio) presenilin promotes aberrant amyloid beta-peptide production and requires a critical aspartate residue for its function in amyloidogenesis.
Leimer U; Lun K; Romig H; Walter J; Grünberg J; Brand M; Haass C
Biochemistry; 1999 Oct; 38(41):13602-9. PubMed ID: 10521267
[TBL] [Abstract][Full Text] [Related]
14. Human presenilin-1, but not familial Alzheimer's disease (FAD) mutants, facilitate Caenorhabditis elegans Notch signalling independently of proteolytic processing.
Baumeister R; Leimer U; Zweckbronner I; Jakubek C; Grünberg J; Haass C
Genes Funct; 1997 Apr; 1(2):149-59. PubMed ID: 9680315
[TBL] [Abstract][Full Text] [Related]
15. Presenilin 2 familial Alzheimer's disease mutations result in partial loss of function and dramatic changes in Abeta 42/40 ratios.
Walker ES; Martinez M; Brunkan AL; Goate A
J Neurochem; 2005 Jan; 92(2):294-301. PubMed ID: 15663477
[TBL] [Abstract][Full Text] [Related]
16. Characterization of human presenilin 1 using N-terminal specific monoclonal antibodies: Evidence that Alzheimer mutations affect proteolytic processing.
Mercken M; Takahashi H; Honda T; Sato K; Murayama M; Nakazato Y; Noguchi K; Imahori K; Takashima A
FEBS Lett; 1996 Jul; 389(3):297-303. PubMed ID: 8766720
[TBL] [Abstract][Full Text] [Related]
17. Brain expression of presenilins in sporadic and early-onset, familial Alzheimer's disease.
Mathews PM; Cataldo AM; Kao BH; Rudnicki AG; Qin X; Yang JL; Jiang Y; Picciano M; Hulette C; Lippa CF; Bird TD; Nochlin D; Walter J; Haass C; Lévesque L; Fraser PE; Andreadis A; Nixon RA
Mol Med; 2000 Oct; 6(10):878-91. PubMed ID: 11126202
[TBL] [Abstract][Full Text] [Related]
18. Characterization of detergent-insoluble complexes containing the familial Alzheimer's disease-associated presenilins.
Parkin ET; Hussain I; Karran EH; Turner AJ; Hooper NM
J Neurochem; 1999 Apr; 72(4):1534-43. PubMed ID: 10098859
[TBL] [Abstract][Full Text] [Related]
19. Carboxyl-terminal fragments of presenilin-1 are closely related to cytoskeletal abnormalities in Alzheimer's brains.
Tomidokoro Y; Ishiguro K; Igeta Y; Matsubara E; Kanai M; Shizuka M; Kawarabayashi T; Harigaya Y; Kawakatsu S; Ii K; Ikeda M; St George-Hyslop PH; Hirai S; Okamoto K; Shoji M
Biochem Biophys Res Commun; 1999 Mar; 256(3):512-8. PubMed ID: 10080929
[TBL] [Abstract][Full Text] [Related]
20. Hyperaccumulation of FAD-linked presenilin 1 variants in vivo.
Lee MK; Borchelt DR; Kim G; Thinakaran G; Slunt HH; Ratovitski T; Martin LJ; Kittur A; Gandy S; Levey AI; Jenkins N; Copeland N; Price DL; Sisodia SS
Nat Med; 1997 Jul; 3(7):756-60. PubMed ID: 9212102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
